Furthermore, mice receiving T cells from brentuximab vedotin–immunized mice showed a trend toward increased CD8 + T-cell infiltration in A20 tumors at take down ( Fig. 5F ).
← all excerpts
Brentuximab Vedotin-Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity.
1
—
—